These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 1335684
1. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: the role of local immunosurveillance. Majewski S, Jablonska S. Am J Med Sci; 1992 Sep; 304(3):174-9. PubMed ID: 1335684 [Abstract] [Full Text] [Related]
2. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Majewski S, Jabłońska S. Arch Dermatol; 1995 Nov; 131(11):1312-8. PubMed ID: 7503577 [Abstract] [Full Text] [Related]
3. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Orth G. Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789 [Abstract] [Full Text] [Related]
4. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis. Majewski S, Malejczyk J, Jablonska S, Misiewicz J, Rudnicka L, Obalek S, Orth G. J Am Acad Dermatol; 1990 Mar; 22(3):423-7. PubMed ID: 2155952 [Abstract] [Full Text] [Related]
5. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. The Nambour Skin Cancer Prevention Study Group. Boxman IL, Russell A, Mulder LH, Bavinck JN, Schegget JT, Green A. Int J Cancer; 2000 Apr 01; 86(1):118-21. PubMed ID: 10728604 [Abstract] [Full Text] [Related]
6. A mouse model for studying epidermodysplasia-verruciformis-associated carcinogenesis. Majewski S, Breitburd F, Skopinska M, Croissant O, Jablonska S, Orth G. Int J Cancer; 1994 Mar 01; 56(5):727-30. PubMed ID: 8314350 [Abstract] [Full Text] [Related]
7. Human papillomaviruses and skin cancer. Pfister H. Semin Cancer Biol; 1992 Oct 01; 3(5):263-71. PubMed ID: 1335790 [Abstract] [Full Text] [Related]
8. Deficiency in Ever2 does not increase susceptibility of mice to pathogenesis by the mouse papillomavirus, MmuPV1. Torres AD, King RE, Uberoi A, Buehler D, Yoshida S, Ward-Shaw E, Lambert PF. J Virol; 2024 Jul 23; 98(7):e0017424. PubMed ID: 38869286 [Abstract] [Full Text] [Related]
9. Oncogenic potential of human papillomaviruses epidermodysplasia verruciformis: a counterpart of Shope papilloma-carcinoma complex. Jabłonska S, Orth G, Obalek S, Croissant O, Jarzabek-Chorzelska M, Favre M, Kremsdorf D. Arch Geschwulstforsch; 1983 Jul 23; 53(3):207-15. PubMed ID: 6311135 [Abstract] [Full Text] [Related]
10. Human papillomavirus type 38 isolated from patients with epidermodysplasia verruciformis. Yutsudo M, Kanda R, Tanigaki T, Kitano Y, Hakura A. Intervirology; 1986 Jul 23; 26(1-2):104-8. PubMed ID: 3032841 [Abstract] [Full Text] [Related]
12. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Majewski S, Jablonska S. Arch Dermatol; 2002 May 23; 138(5):649-54. PubMed ID: 12020228 [Abstract] [Full Text] [Related]
13. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis. Padlewska K, Ramoz N, Cassonnet P, Riou G, Barrois M, Majewski S, Croissant O, Jablonska S, Orth G. J Invest Dermatol; 2001 Oct 23; 117(4):935-42. PubMed ID: 11676835 [Abstract] [Full Text] [Related]
18. [Pathogenesis of human papillomavirus infection in patients with epidermodysplasia verruciformis]. Liang S, Zuo YG, Wang BX. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb 23; 31(1):93-6. PubMed ID: 19317070 [Abstract] [Full Text] [Related]